Article
Promoter haplotype structure of solute carrier 22 member 2 (SLC22A2) in the Xhosa population of South Africa and their differential effect on gene expression.
Gene - 30 Apr 2022
Abrahams-October Zainonesa, Lloyd Sheridon, Pearce Brendon, Johnson Rabia, Benjeddou Mongi
Abstract excerpt
SLC22A2 is abundantly expressed in the kidney and facilitates the transport of endogenous and exogenous cationic compounds. It plays a pivotal role in the transport of pharmacologically important compounds such as metformin, cisplatin, lamivudine and cimetidine. Polymorphisms within SLC22A2 could potentially contribute to the inter-individual variable response to drugs. The SLC22A2 gene is known to show...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
